Selected Scientific Publications
Park GY, Wilson JJ, Song Y, and Lippard SJ. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile. PNAS. 2012 Jul 24; 109 (30): 11987-92.
Dhar S, Kolishetti N, Lippard SJ, Farokhzad OC. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. PNAS. 2011 Feb 1; 108 (5): 1850-1855.
Kolishetti N, Dhar S, Valencia PM, Lin LQ, Karnik R, Lippard SJ, Langer R, Farokhzad OC. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. PNAS. 2010 Oct 19; 107 (42): 17939-17944.
Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. PNAS. 2008 Nov 11; 105 (45): 17356-17361.